Could a routine blood test improve dementia outcomes? Researchers are hoping a simple blood protein point-of-care test will aid early detection of cognitive impairment.
DoH confirms vaccine indemnity scheme, but questions remain ‘You shouldn’t fear that you’re going to get tied up in complicated litigation if something – despite your best efforts – goes wrong,’ the DoH First Assistant Secretary has told GPs.
National Cabinet announces no-fault indemnity scheme for GPs to administer AstraZeneca The move opens the door for under-60s to receive the vaccine as the country looks to speed up the rollout amid a potential national outbreak.
New AstraZeneca guidance reinforces need for vaccine counselling MBS numbers The decision to limit the use of AstraZeneca’s COVID vaccine to only people aged 60 and older will likely place more pressure on GPs dealing with vaccine-hesitant patients.
History of blood clots not usually a reason to avoid AstraZeneca Patients who have had blood clots or take blood thinners often ask these two haematologists, ‘Should I have the AstraZeneca vaccine?’
Identifying and treating vaccine-linked blood clots in general practice Other than age, there are ‘no known risk factors’ associated with developing blood clots with low platelets following an AstraZeneca vaccination, but GPs can still take steps to protect patients.
Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.
Five new cases of blood clots likely linked to AstraZeneca But evidence indicates the benefits of the vaccine still outweigh the risks, according to the TGA.
Antihypertensives may benefit people with normal blood pressure But experts worry about the potential real-world benefits and harms of putting ‘millions more’ people on these drugs.
Over-50s can now get their COVID vaccine: What do they need to know? Amid reports of blood clots and increasing vaccine hesitancy, patients will likely have questions as the next phase of the rollout gets underway.